Child Neurology: Brown-Vialetto-Van Laere syndrome: Dramatic visual recovery after delayed riboflavin therapy.
作者信息
Bamaga Ahmed K, Maamari Robi N, Culican Susan M, Shinawi Marwan, Golumbek Paul T
机构信息
From the Departments of Neurology (A.K.B., P.T.G.) and Ophthalmology and Visual Sciences (R.N.M., S.M.C.) and Division of Genetics and Genomic Medicine, Department of Pediatrics (M.S.), Washington University School of Medicine, St Louis, MO; and Department of Pediatrics (A.K.B.), King Abdulaziz University, Jeddah, Saudi Arabia.
出版信息
Neurology. 2018 Nov 13;91(20):938-941. doi: 10.1212/WNL.0000000000006498.
Abstract
摘要
相似文献
1
Child Neurology: Brown-Vialetto-Van Laere syndrome: Dramatic visual recovery after delayed riboflavin therapy.
Neurology. 2018 Nov 13;91(20):938-941. doi: 10.1212/WNL.0000000000006498.
2
Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome.
Pract Neurol. 2017 Jan;17(1):53-56. doi: 10.1136/practneurol-2016-001488. Epub 2016 Oct 24.
3
Reversible posterior column dysfunction in Brown-Vialetto-Von Laere syndrome.
Muscle Nerve. 2017 Oct;56(4):E28-E31. doi: 10.1002/mus.25694. Epub 2017 Jun 6.
4
Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
Pediatr Neurol. 2012 Jun;46(6):407-9. doi: 10.1016/j.pediatrneurol.2012.03.008.
5
Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features.
Eur J Paediatr Neurol. 2014 Mar;18(2):231-4. doi: 10.1016/j.ejpn.2013.09.006. Epub 2013 Oct 16.
6
Dramatic Improvement of a Rare Syndrome With High Dose Riboflavin Treatment.
Pediatr Neurol. 2018 Sep;86:77-78. doi: 10.1016/j.pediatrneurol.2018.05.005. Epub 2018 Jun 1.
7
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
Parkinsonism Relat Disord. 2019 Apr;61:245-247. doi: 10.1016/j.parkreldis.2018.10.017. Epub 2018 Oct 15.
8
A Case Report of Riboflavin Treatment and Cochlear Implants in a 4-Year-Old Girl with Progressive Hearing Loss and Delayed Speech Development: Brown-Vialetto-Van Laere Syndrome.
Am J Case Rep. 2023 Oct 3;24:e940439. doi: 10.12659/AJCR.940439.
9
Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation.
BMJ Case Rep. 2018 Jun 27;2018:bcr-2018-224958. doi: 10.1136/bcr-2018-224958.
10
A case report of sudden-onset auditory neuropathy spectrum disorder associated with Brown-Vialetto-Van Laere syndrome (riboflavin transporter deficiency).
Int J Audiol. 2022 Mar;61(3):258-264. doi: 10.1080/14992027.2021.1921291. Epub 2021 May 13.
引用本文的文献
1
Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations.
Dev Med Child Neurol. 2025 Mar;67(3):405-415. doi: 10.1111/dmcn.16083. Epub 2024 Sep 9.
2
Alteration of Flavin Cofactor Homeostasis in Human Neuromuscular Pathologies.
Methods Mol Biol. 2021;2280:275-295. doi: 10.1007/978-1-0716-1286-6_18.
3
Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines.
Curr Opin Pediatr. 2020 Dec;32(6):707-718. doi: 10.1097/MOP.0000000000000954.
4
Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency.
Oxid Med Cell Longev. 2020 Aug 12;2020:6821247. doi: 10.1155/2020/6821247. eCollection 2020.
5
Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.
Int J Mol Sci. 2020 Jul 26;21(15):5310. doi: 10.3390/ijms21155310.
本文引用的文献
1
Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.
Brain. 2017 Nov 1;140(11):2820-2837. doi: 10.1093/brain/awx231.
2
Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing.
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000265. doi: 10.1101/mcs.a000265.
3
Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.
J Inherit Metab Dis. 2016 Jul;39(4):559-64. doi: 10.1007/s10545-016-9924-2. Epub 2016 Mar 14.
4
Brown-Vialetto-Van Laere syndrome: a 28-year follow-up.
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):681-2. doi: 10.1136/jnnp-2014-310088. Epub 2015 Oct 6.
5
Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report.
Clin Neurol Neurosurg. 2015 Jan;128:1-3. doi: 10.1016/j.clineuro.2014.10.016. Epub 2014 Nov 4.
6
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
Brain. 2014 Jan;137(Pt 1):44-56. doi: 10.1093/brain/awt315. Epub 2013 Nov 19.
7
Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome.
J Inherit Metab Dis. 2012 Nov;35(6):943-8. doi: 10.1007/s10545-012-9513-y. Epub 2012 Aug 3.
8
Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.
Brain. 2012 Sep;135(Pt 9):2875-82. doi: 10.1093/brain/aws161. Epub 2012 Jun 26.
9
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
J Inherit Metab Dis. 2011 Feb;34(1):159-64. doi: 10.1007/s10545-010-9242-z. Epub 2010 Nov 26.
10
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.
Am J Hum Genet. 2010 Mar 12;86(3):485-9. doi: 10.1016/j.ajhg.2010.02.006. Epub 2010 Mar 4.
Zotero 插件